99 related articles for article (PubMed ID: 31177467)
1. Comparative Analysis of Blood Plasma Proteome in Patients with Renal Cell Carcinoma.
Kaysheva AL; Kopylov AT; Kushlinskii NE; Gershtein ES; Alferov AA; Morozov AA; Kazantseva IA; Pleshakova TO; Archakov AI; Ivanov YD
Bull Exp Biol Med; 2019 May; 167(1):91-96. PubMed ID: 31177467
[TBL] [Abstract][Full Text] [Related]
2. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy.
Gbormittah FO; Lee LY; Taylor K; Hancock WS; Iliopoulos O
J Proteome Res; 2014 Nov; 13(11):4889-900. PubMed ID: 25184692
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-mass spectrometry based serum peptidomic approach for renal clear cell carcinoma diagnosis.
Huang Z; Zhang S; Hang W; Chen Y; Zheng J; Li W; Xing J; Zhang J; Zhu E; Yan X
J Pharm Biomed Anal; 2014 Nov; 100():175-183. PubMed ID: 25168216
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Prieto DA; Johann DJ; Wei BR; Ye X; Chan KC; Nissley DV; Simpson RM; Citrin DE; Mackall CL; Linehan WM; Blonder J
Biomark Med; 2014; 8(2):269-86. PubMed ID: 24521024
[TBL] [Abstract][Full Text] [Related]
8. Plasma proteome profiling of von Hippel-Lindau disease after total and subtotal nephrectomy: a preliminary study.
Opatrná S; Chiangjong W; Korabecná M; Sintiprungrat K; Sinchaikul S; Chen ST; Matejovic M; Thongboonkerd V
Clin Biochem; 2010 Jan; 43(1-2):142-9. PubMed ID: 19715686
[TBL] [Abstract][Full Text] [Related]
9. KYSS: mass spectrometry data quality assessment for protein analysis and large-scale proteomics.
Such-Sanmartín G; Sidoli S; Ventura-Espejo E; Jensen ON
Biochem Biophys Res Commun; 2014 Mar; 445(4):702-7. PubMed ID: 24480439
[TBL] [Abstract][Full Text] [Related]
10. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
11. Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma.
Johann DJ; Wei BR; Prieto DA; Chan KC; Ye X; Valera VA; Simpson RM; Rudnick PA; Xiao Z; Issaq HJ; Linehan WM; Stein SE; Veenstra TD; Blonder J
Anal Chem; 2010 Mar; 82(5):1584-8. PubMed ID: 20121140
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
13. Mixed-mode ion exchange-based integrated proteomics technology for fast and deep plasma proteome profiling.
Xue L; Lin L; Zhou W; Chen W; Tang J; Sun X; Huang P; Tian R
J Chromatogr A; 2018 Aug; 1564():76-84. PubMed ID: 29935814
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards.
Kramer G; Woolerton Y; van Straalen JP; Vissers JP; Dekker N; Langridge JI; Beynon RJ; Speijer D; Sturk A; Aerts JM
PLoS One; 2015; 10(10):e0140097. PubMed ID: 26474480
[TBL] [Abstract][Full Text] [Related]
16. Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.
Smith J; Davey G; Polom K; Roviello F; Bones J
J Chromatogr A; 2018 Sep; 1566():32-43. PubMed ID: 29945787
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of formalin-fixed, paraffin-embedded clear cell renal cell carcinoma tissue using stable isotopic dimethylation of primary amines.
Weißer J; Lai ZW; Bronsert P; Kuehs M; Drendel V; Timme S; Kuesters S; Jilg CA; Wellner UF; Lassmann S; Werner M; Biniossek ML; Schilling O
BMC Genomics; 2015 Jul; 16(1):559. PubMed ID: 26220445
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.
Prieto DA; Chan KC; Johann DJ; Ye X; Whitely G; Blonder J
Methods Mol Biol; 2017; 1647():71-90. PubMed ID: 28808996
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.
Xu G; Xiang CQ; Lu Y; Wang WJ; Kang XN; Liao P; Ding Q; Zhang YF
Technol Cancer Res Treat; 2009 Jun; 8(3):225-30. PubMed ID: 19445540
[TBL] [Abstract][Full Text] [Related]
20. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome.
Qian WJ; Liu T; Monroe ME; Strittmatter EF; Jacobs JM; Kangas LJ; Petritis K; Camp DG; Smith RD
J Proteome Res; 2005; 4(1):53-62. PubMed ID: 15707357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
